Purdue University
West Lafayette, Indiana, 47909, United States
NCT Number: NCT03409484
Assess the impact of 100% grape juice on postprandial glycemic response and subsequent appetite, food intake and cognitive function.
Looking for future studies?
Notify Me25 year–60 year
All sexes
Interventional
Not applicable
West Lafayette, Indiana, 47909, United States
Investigators earlier clinical work and published literature suggest that the phenolic content and strong flavor intensity of 100% Concord grape juice hold potential beneficial effects on appetite and glycemia. Investigators aim to better understand the use of 100% grape juice modifies appetite and glycemia acutely and over the day using a 24 hour glucose monitor.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Concord Grape Juice
Low flavoniod low essence beverage
Low flavonoid beverage
Time frame: 24 hours
samples taken every 5 minutes for 24 hours by a continuous glucose monitor
Time frame: 24 hours
Questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly on same day as grape juice intervention
Purdue University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03409497
Appetitive Behavior, Behavior
West Lafayette, Indiana, United States
View Trial DetailsNCT03066713
Appetitive Behavior, Behavior
West Lafayette, Indiana, United States
View Trial DetailsNCT07243743
Glycemic Response
Toronto, Ontario, Canada
View Trial DetailsNCT07175740
Behavior, Diabetes Mellitus
Québec, Quebec, Canada
View Trial Details